SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Feb 6, 2008
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: Feb. 6, 2008 · CIK: 0001326205 · Accession: 0001185185-08-000081
AI Filing Summary & Sentiment
Referenced dates: February 6, 2008
Show Raw Text
CORRESP
1
filename1.htm
indiacorresp-262008.htm
Writer’s
direct phone
(312)
460-5962
Writer’s
e-mail
mblount@seyfarth.com
131
South Dearborn Street
Suite
2400
Chicago,
Illinois 60603
(312)
460-5000
fax
(312) 460-7000
www.seyfarth.com
February
6, 2008
VIA
EDGAR
Securities
and Exchange Commission
100 F
Street, N.E.
Washington,
D.C. 20549
Attn: Pamela
A. Long
Assistant
Director
Division
of Corporation Finance
Re:
India
Globalization Capital, Inc.
Preliminary
Proxy Statement on Schedule 14A
File
No. 1-32830
Dear Ms.
Long:
This
letter is intended to respond to the comments set forth in your letter dated
February 6, 2008 (the “Comment Letter”) with respect to the Amended Preliminary
Proxy Statement on Schedule 14A (the “Amended Proxy Statement”) filed by India
Globalization Capital, Inc. (the “Company”) on February 1, 2008. As
suggested in the Comment Letter, if these responses are acceptable to the
Commission, we will incorporate the changes into the Company’s Definitive Proxy
Statement. The numbered paragraphs below correspond to the numbered
comments in the Comment Letter. Page references are to pages in the
Amended Proxy Statement.
General
1. The
Company anticipates mailing the Definitive Proxy Statement to shareholders on or
before February 11, 2008. The Company acknowledges that if the Definitive Proxy
Statement is not mailed by February 11, 2008, it may be required to update the
financial statements in the Definitive Proxy Statement.
Table
of Contents, page vi
2. We
will appropriately revise descriptions of the Annexes in the Table of Contents
and the references within the Definitive Proxy Statement to the
annexes. With respect to certain of the Commission’s specific
comments on this point:
·
The
description of Annex F in the Table of Contents will read as
follows: “Annex F: Amendment to the Share Subscription
Agreement Dated September 16, 2007, entered into on December 21, 2007 by
and among India Globalization Capital, Inc., Techni Bharathi Limited and
the persons named as Promoters
therein.”
·
The
description of Annex I in the Table of Contents will read as follows:
“Annex I: Letter Agreement dated January 8, 2008 by and among India
Globalization Capital, Inc., Odeon Limited, and Techni Bhararti Limited
amending the Share Purchase Agreement dated September 21, 2007 by and
among India Globalization Capital, Inc. and Odeon
Limited”. This is consistent with the Company’s description of
the agreement elsewhere in the Proxy Statement. See, e.g., the following
disclosure under the caption “Odeon Share Purchase Agreement” on page 67
of the Amended Proxy Statement: “On January 8, 2008, IGC
entered into a letter agreement with TBL and Odeon (the “Odeon Amendment”)
amending the Odeon Purchase
Agreement.”
·
The
references to the acquisition agreements being attached as annexes A-G is
inadvertent and will be revised to refer to annexes
A-I.
·
The
references to the CWEL agreements as being attached as annexes I and J is
inadvertent and will be revised to refer to annexes J and
K.
·
The
references to the stock plan as being attached as annex K is inadvertent
and will be revised to refer to annex
L.
Writer’s
direct phone
(312)
460-5962
Writer’s
e-mail
mblount@seyfarth.com
Securities
and Exchange Commission
Attn: Pamela
A. Long
February
6, 2008
Page
2
Q.
If I have conversion rights, how do I exercise them?, page 21
3. The
reference to $5.82 is inadvertent. We will revise the language in the Definitive
Proxy Statement to read as follows: “Based on the amount of cash held
in the trust account as of September 30, 2007, including interest accrued as of
that date and net of estimated taxes, you will be entitled to convert each share
of common stock that you hold into approximately $5.89”.
Comparable
Transactions, page 51
4. We
will add the following sentence to the end of the paragraph following the table
in the “Comparable Transactions” Section: “The total amount of money
in escrow as on September 30, 2007 is $67,091,690.”.
Closing
The Company acknowledges
that:
(a) the Company is
responsible for the adequacy of the disclosure in the filings;
(b) staff comments or
changes to disclosure in response to staff comments do not foreclose the
Commission from taking any action with respect to the filings; and
(c) the Company may not
assert staff comments as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United
States.
The Company appreciates the staff’s
comments with respect to the Proxy Statement. If you have any
questions with respect to this letter, please contact the undersigned at (312)
460-5962.
Very
truly yours,
SEYFARTH
SHAW LLP
/s/
Michael Blount
Michael
E. Blount
cc:
Ram
Mukunda
Edward
M. Kelly